BENIGN BONE TUMORS: WHY USE CERAMENT®

CERAMENT augments the management of bone tumors

Injectibilty

Radiopacity

High local concentration of antibiotic

Remodels into bone within 6 -12 months

For benign bone tumors requiring surgical intervention either as a result of pathologic fracture or the risk of fracture, CERAMENT®|BONE VOID FILLER offers injectability through a 16G needle, flowability and radiopacity, making it ideal for either open or percutaneous surgery and offering complete void filling.

CERAMENT|BONE VOID FILLER remodels into host bone within 6-12 months, reducing the risk of re-fracture.

For high-risk patients, CERAMENT®|G and CERAMENT® V can additionally offer a high local concentration of antibiotics to protect implants and bone healing.